Metropolitan Bank Announces Pricing of Public Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 26 2026
0mins
Should l Buy MCB?
Source: Newsfilter
- Offering Size: Metropolitan Bank is pricing its public offering at $85.00 per share for 2,100,000 shares, aiming for gross proceeds of approximately $178.5 million, which could rise to $205.3 million if underwriters fully exercise their option, indicating strong market demand for the bank's shares.
- Use of Proceeds: The funds raised will support the company's organic growth initiatives, investments in the bank, working capital for ongoing operations, and general corporate purposes, reflecting the company's proactive strategy to enhance its competitive position in the market.
- Underwriter Selection: UBS Investment Bank and Hovde Group are acting as joint book-running managers for the offering, showcasing the company's professional partnerships in the capital markets, which is expected to boost investor confidence and enhance stock liquidity.
- Compliance Statement: The company has filed an effective shelf registration statement with the SEC, emphasizing that the offering will be conducted solely through a written prospectus that meets securities law requirements, ensuring comprehensive disclosure for investors and mitigating legal risks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MCB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MCB
Wall Street analysts forecast MCB stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 79.620
Low
86.00
Averages
88.00
High
90.00
Current: 79.620
Low
86.00
Averages
88.00
High
90.00
About MCB
Metropolitan Bank Holding Corp. is a bank holding company. The Company, through its subsidiary, Metropolitan Commercial Bank, a New York state-chartered commercial bank, provides a range of business, commercial and retail banking products and services to small businesses, middle-market enterprises, public entities and affluent individuals in the New York metropolitan area. In addition to traditional commercial banking products, the Company offers corporate cash management and retail banking services; customized financial solutions for government entities, municipalities, public institutions and charter schools; specialized services to facilitate secure and efficient real estate transactions and tax-deferred exchanges for title and escrow and Section 1031 exchanges; and EB-5 Program accounts for qualified foreign investors. Its commercial real estate products include acquisition loans, renovation loans, loans on owner-occupied properties and construction loans.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wagner College to Honor Jane V. DeFazio with Humanitarian Award
- Humanitarian Award Presentation: Wagner College will honor Dr. Jane V. DeFazio and Mark R. DeFazio with the Monroe J. Klein '66 Humanitarian Award at the 2026 Community Mitzvah Awards Dinner, recognizing their long-standing commitment to education and humanitarian initiatives, highlighting their significant roles in community service.
- Awards Dinner Details: The awards dinner is scheduled for March 18, 2026, from 6:00 PM to 10:00 PM at Wagner College's Union Dining Hall in Staten Island, New York, aimed at celebrating individuals who have excelled in Jewish life and promoting unity and leadership within the community.
- Education and Compassion: Dr. Jane V. DeFazio, an Associate Professor at Wagner College's School of Nursing, is dedicated to fostering empathy and reflective practice in future nurses, with research exploring the intersection of healthcare and Holocaust history, reflecting her passion for education and support for humanitarian efforts.
- Business and Philanthropy: Mark R. DeFazio, Founder and CEO of Metropolitan Commercial Bank, has transformed the institution from a community bank into a leading NYSE-listed commercial bank, actively supporting educational and charitable organizations, demonstrating a balance between business success and social responsibility.
See More
Metropolitan Commercial Bank Expands National Healthcare Lending Platform
- HUD Approval: Metropolitan Commercial Bank has received approval from the U.S. Department of Housing and Urban Development to participate in the Multifamily Accelerated Processing (MAP) and LEAN (Section 232) programs, which authorizes the bank to issue FHA-insured loans for healthcare facilities nationwide, significantly enhancing its competitive position in the healthcare lending market.
- Strategic Expansion: This approval marks a significant strategic expansion of the bank's commercial healthcare lending platform, expected to attract high-quality, low-cost deposits, thereby strengthening the bank's earnings profile and funding base while reinforcing its status as a leading healthcare lender.
- Flexible Financing Solutions: Through the FHA 232 program, the bank can provide long-term, fixed-rate financing solutions that meet the healthcare sector's demand for stable capital, supporting operators in acquisitions and refinancing, which promotes sustained growth in the industry.
- Marketing Initiative: Metropolitan Commercial Bank plans to actively market its HUD MAP/LEAN lending platform immediately, which is expected to offer flexible financing options for healthcare facilities, further enhancing its market share and influence in the healthcare lending sector.
See More
Metropolitan Bank Launches Public Offering of Common Stock
- Offering Size: Metropolitan Bank (MCB) priced an underwritten public offering of 2.1 million shares of common stock at $85.00 per share, with gross proceeds expected to be approximately $178.5 million, potentially rising to $205.3 million if underwriters exercise their 15% option.
- Use of Proceeds: The net proceeds from this offering will support the bank's organic growth initiatives, investments, working capital for ongoing operations, and general corporate purposes, indicating a strategic focus on future development.
- Market Reaction: Following the announcement of the public offering, MCB's stock price dropped 1.3% in pre-market trading on Thursday, reflecting a cautious market sentiment that may impact investor confidence.
- Future Outlook: Metropolitan Bank aims for a 12% loan growth and modest net interest margin expansion in 2026 while expanding its branch presence, signaling the company's pursuit of further growth opportunities in a competitive market.
See More
Metropolitan Bank Prices Public Offering at $85 per Share
- Offering Size: Metropolitan Bank has announced a public offering of 2.1 million shares priced at $85 each, resulting in gross proceeds of $178.5 million, indicating strong market demand for its stock.
- Underwriter Option: The underwriters have a 30-day option to purchase an additional 15% of the shares, which, if fully exercised, would raise total proceeds to approximately $205.3 million, further strengthening the company's capital base.
- Use of Proceeds: The net proceeds from the offering will be utilized to support the bank's organic growth initiatives, investments, and general corporate purposes, reflecting the company's proactive approach to future development.
- Underwriting Team: UBS Investment Bank and Hovde Group LLC are serving as joint book-running managers, showcasing the company's professional support in capital markets, with the offering expected to close on February 27.
See More
Metropolitan Bank Holding Corp. Announces Public Offering of Common Stock
- Offering Size: Metropolitan Bank Holding Corp. has priced an underwritten public offering of 2,100,000 shares at $85.00 each, expecting gross proceeds of approximately $178.5 million, which could rise to $205.3 million if underwriters fully exercise their option, indicating strong market demand for its stock.
- Clear Use of Proceeds: The company plans to utilize the net proceeds from the offering to support organic growth initiatives, investments in the Bank, working capital for ongoing operations, and general corporate purposes, reflecting a proactive stance towards future expansion.
- Underwriter Selection: UBS Investment Bank and Hovde Group are acting as joint book-running managers for the offering, showcasing their influence and expertise in the capital markets, which is expected to provide robust market support for the company.
- Compliance and Transparency: The company has filed an effective shelf registration statement with the SEC, including a preliminary prospectus supplement, ensuring that investors can access comprehensive information before investing, thereby enhancing market trust in its transparency.
See More
Metropolitan Bank Announces Pricing of Public Offering
- Offering Size: Metropolitan Bank is pricing its public offering at $85.00 per share for 2,100,000 shares, aiming for gross proceeds of approximately $178.5 million, which could rise to $205.3 million if underwriters fully exercise their option, indicating strong market demand for the bank's shares.
- Use of Proceeds: The funds raised will support the company's organic growth initiatives, investments in the bank, working capital for ongoing operations, and general corporate purposes, reflecting the company's proactive strategy to enhance its competitive position in the market.
- Underwriter Selection: UBS Investment Bank and Hovde Group are acting as joint book-running managers for the offering, showcasing the company's professional partnerships in the capital markets, which is expected to boost investor confidence and enhance stock liquidity.
- Compliance Statement: The company has filed an effective shelf registration statement with the SEC, emphasizing that the offering will be conducted solely through a written prospectus that meets securities law requirements, ensuring comprehensive disclosure for investors and mitigating legal risks.
See More
Wagner College to Honor Jane V. DeFazio with Humanitarian Award
- Humanitarian Award Presentation: Wagner College will honor Dr. Jane V. DeFazio and Mark R. DeFazio with the Monroe J. Klein '66 Humanitarian Award at the 2026 Community Mitzvah Awards Dinner, recognizing their long-standing commitment to education and humanitarian initiatives, highlighting their significant roles in community service.
- Awards Dinner Details: The awards dinner is scheduled for March 18, 2026, from 6:00 PM to 10:00 PM at Wagner College's Union Dining Hall in Staten Island, New York, aimed at celebrating individuals who have excelled in Jewish life and promoting unity and leadership within the community.
- Education and Compassion: Dr. Jane V. DeFazio, an Associate Professor at Wagner College's School of Nursing, is dedicated to fostering empathy and reflective practice in future nurses, with research exploring the intersection of healthcare and Holocaust history, reflecting her passion for education and support for humanitarian efforts.
- Business and Philanthropy: Mark R. DeFazio, Founder and CEO of Metropolitan Commercial Bank, has transformed the institution from a community bank into a leading NYSE-listed commercial bank, actively supporting educational and charitable organizations, demonstrating a balance between business success and social responsibility.
See More
Metropolitan Commercial Bank Expands National Healthcare Lending Platform
- HUD Approval: Metropolitan Commercial Bank has received approval from the U.S. Department of Housing and Urban Development to participate in the Multifamily Accelerated Processing (MAP) and LEAN (Section 232) programs, which authorizes the bank to issue FHA-insured loans for healthcare facilities nationwide, significantly enhancing its competitive position in the healthcare lending market.
- Strategic Expansion: This approval marks a significant strategic expansion of the bank's commercial healthcare lending platform, expected to attract high-quality, low-cost deposits, thereby strengthening the bank's earnings profile and funding base while reinforcing its status as a leading healthcare lender.
- Flexible Financing Solutions: Through the FHA 232 program, the bank can provide long-term, fixed-rate financing solutions that meet the healthcare sector's demand for stable capital, supporting operators in acquisitions and refinancing, which promotes sustained growth in the industry.
- Marketing Initiative: Metropolitan Commercial Bank plans to actively market its HUD MAP/LEAN lending platform immediately, which is expected to offer flexible financing options for healthcare facilities, further enhancing its market share and influence in the healthcare lending sector.
See More
Metropolitan Bank Launches Public Offering of Common Stock
- Offering Size: Metropolitan Bank (MCB) priced an underwritten public offering of 2.1 million shares of common stock at $85.00 per share, with gross proceeds expected to be approximately $178.5 million, potentially rising to $205.3 million if underwriters exercise their 15% option.
- Use of Proceeds: The net proceeds from this offering will support the bank's organic growth initiatives, investments, working capital for ongoing operations, and general corporate purposes, indicating a strategic focus on future development.
- Market Reaction: Following the announcement of the public offering, MCB's stock price dropped 1.3% in pre-market trading on Thursday, reflecting a cautious market sentiment that may impact investor confidence.
- Future Outlook: Metropolitan Bank aims for a 12% loan growth and modest net interest margin expansion in 2026 while expanding its branch presence, signaling the company's pursuit of further growth opportunities in a competitive market.
See More
Metropolitan Bank Prices Public Offering at $85 per Share
- Offering Size: Metropolitan Bank has announced a public offering of 2.1 million shares priced at $85 each, resulting in gross proceeds of $178.5 million, indicating strong market demand for its stock.
- Underwriter Option: The underwriters have a 30-day option to purchase an additional 15% of the shares, which, if fully exercised, would raise total proceeds to approximately $205.3 million, further strengthening the company's capital base.
- Use of Proceeds: The net proceeds from the offering will be utilized to support the bank's organic growth initiatives, investments, and general corporate purposes, reflecting the company's proactive approach to future development.
- Underwriting Team: UBS Investment Bank and Hovde Group LLC are serving as joint book-running managers, showcasing the company's professional support in capital markets, with the offering expected to close on February 27.
See More
Metropolitan Bank Holding Corp. Announces Public Offering of Common Stock
- Offering Size: Metropolitan Bank Holding Corp. has priced an underwritten public offering of 2,100,000 shares at $85.00 each, expecting gross proceeds of approximately $178.5 million, which could rise to $205.3 million if underwriters fully exercise their option, indicating strong market demand for its stock.
- Clear Use of Proceeds: The company plans to utilize the net proceeds from the offering to support organic growth initiatives, investments in the Bank, working capital for ongoing operations, and general corporate purposes, reflecting a proactive stance towards future expansion.
- Underwriter Selection: UBS Investment Bank and Hovde Group are acting as joint book-running managers for the offering, showcasing their influence and expertise in the capital markets, which is expected to provide robust market support for the company.
- Compliance and Transparency: The company has filed an effective shelf registration statement with the SEC, including a preliminary prospectus supplement, ensuring that investors can access comprehensive information before investing, thereby enhancing market trust in its transparency.
See More
Metropolitan Bank Announces Pricing of Public Offering
- Offering Size: Metropolitan Bank is pricing its public offering at $85.00 per share for 2,100,000 shares, aiming for gross proceeds of approximately $178.5 million, which could rise to $205.3 million if underwriters fully exercise their option, indicating strong market demand for the bank's shares.
- Use of Proceeds: The funds raised will support the company's organic growth initiatives, investments in the bank, working capital for ongoing operations, and general corporate purposes, reflecting the company's proactive strategy to enhance its competitive position in the market.
- Underwriter Selection: UBS Investment Bank and Hovde Group are acting as joint book-running managers for the offering, showcasing the company's professional partnerships in the capital markets, which is expected to boost investor confidence and enhance stock liquidity.
- Compliance Statement: The company has filed an effective shelf registration statement with the SEC, emphasizing that the offering will be conducted solely through a written prospectus that meets securities law requirements, ensuring comprehensive disclosure for investors and mitigating legal risks.
See More
